IVKAX
Price
$19.72
Change
-$0.09 (-0.45%)
Updated
Sep 5 closing price
Net Assets
243.67M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

IVKAX vs VIVIX

Header iconIVKAX vs VIVIX Comparison
Open Charts IVKAX vs VIVIXBanner chart's image
VY® Invesco Comstock A
Price$19.72
Change-$0.09 (-0.45%)
VolumeN/A
Net Assets243.67M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
IVKAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IVKAX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVKAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. IVKAX (244M). VIVIX pays higher dividends than IVKAX: VIVIX (2.11) vs IVKAX (1.44). IVKAX was incepted earlier than VIVIX: IVKAX (23 years) vs VIVIX (27 years). IVKAX (1.30) is less costly to investors than VIVIX (0.04). IVKAX is a more actively managed with annual turnover of: 23.00 vs. VIVIX (9.00). IVKAX has a lower initial minimum investment than VIVIX: IVKAX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. IVKAX (-0.66). VIVIX return over 5 years is better than : 70.16 vs. IVKAX (51.66).
IVKAXVIVIXIVKAX / VIVIX
Total Expense Ratio1.200.043,000%
Annual Report Gross Expense Ratio1.300.043,250%
Fund Existence23 years27 years-
Gain YTD-3.1677.866-40%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets244M203B0%
Annual Yield % from dividends1.442.1168%
Returns for 1 year-0.667.74-9%
Returns for 3 years3.9736.6111%
Returns for 5 years51.6670.1674%
Returns for 10 years51.81131.6139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia